References
- Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003;289:179-86. https://doi.org/10.1001/jama.289.2.179
- Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, et al. Influenza-associated hospitalizations in the United States. JAMA 2004;292:1333-40. https://doi.org/10.1001/jama.292.11.1333
- Fiore AE, Shay DK, Broder K, Iskander JK, Uyeki TM, Mootrey G, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 2009;58(RR-8):1-52.
- Cheong HJ, Song JY, Park JW, Yeon JE, Byun KS, Lee CH, et al. Humoral and cellular immune responses to influenza vaccine in patients with advanced cirrhosis. Vaccine 2006;24:2417-22. https://doi.org/10.1016/j.vaccine.2005.11.064
- Fiore AE, Shay DK, Broder K, Iskander JK, Uyeki TM, Mootrey G, et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep 2008;57(RR-7):1-60.
- Organization for Economic Cooperation and Development (OECD). 2015 Influenza vaccination rates [Internet]. Paris: OECD; c2018 [cited 2018 Mar 17]. Available from: https://data.oecd.org.
- Korean Statistical Information Service. 2015 Influenza vaccination rate for children and adolescents [Internet]. Daejeon: Statistics Korea; 2015 [cited 2018 Mar 17]. Available from: http://kosis.kr.
- Kim YK, Eun BW, Lee TJ, Lee J, Kim KH, Kim DH, et al. Immunogenicity and safety of a cell culture-derived inactivated quadrivalent influenza vaccine (NBP607-QIV) in South Korean children and adolescents: a randomized, double-blind, multi-center, phase 3 clinical trial. Open Forum Infect Dis 2016;3 Suppl 1:S201.
- Cintra OA, Rey LC. Safety, immunogenicity and efficacy of influenza vaccine in children. J Pediatr (Rio J) 2006;82(3 Suppl):S83-90. https://doi.org/10.1590/S0021-75572006000400010
- Wright PF. The use of inactivated influenza vaccine in children. Semin Pediatr Infect Dis 2006;17:200-5. https://doi.org/10.1053/j.spid.2006.08.004
- Han SB, Rhim JW, Shin HJ, Lee SY, Kim HH, Kim JH, et al. Immunogenicity and safety assessment of a trivalent, inactivated split influenza vaccine in Korean children: Double-blind, randomized, active-controlled multicenter phase III clinical trial. Hum Vaccin Immunother 2015;11:1094-102. https://doi.org/10.1080/21645515.2015.1017693
- Committee for Medicinal Products for Human Use. Guideline on dossier structure and content for pandemic influenza vaccine marketing authorisation application [Internet]. London: European Medicines Agency; 2008 [cited 2018 Mar 17]. Available from: http://www.ema.europa.eu.
- Committee for Proprietary Medicinal Products. Note for guidance on harmonisation of requirements for influenza vaccines [Internet]. London: European Agency for the Evaluation of Medicinal Products; 1997 [cited 2018 Mar 17]. Available from: http://www.ema.europa.eu.
- Walter EB, Rajagopal S, Zhu Y, Neuzil KM, Fairchok MP, Englund JA. Trivalent inactivated influenza vaccine (TIV) immunogenicity in children 6 through 23 months of age: do children of all ages respond equally? Vaccine 2010;28:4376-83. https://doi.org/10.1016/j.vaccine.2010.04.058
- Seidman JC, Richard SA, Viboud C, Miller MA. Quantitative review of antibody response to inactivated seasonal influenza vaccines. Influenza Other Respir Viruses 2012;6:52-62. https://doi.org/10.1111/j.1750-2659.2011.00268.x
- Langley JM, Vanderkooi OG, Garfield HA, Hebert J, Chandrasekaran V, Jain VK, et al. Immunogenicity and safety of 2 dose levels of a thimerosal-free trivalent seasonal influenza vaccine in children aged 6-35 months: a randomized, controlled trial. J Pediatric Infect Dis Soc 2012;1:55-63. https://doi.org/10.1093/jpids/pis012
- Yang P, Thompson MG, Ma C, Shi W, Wu S, Zhang D, et al. Influenza vaccine effectiveness against medically-attended influenza illness during the 2012-2013 season in Beijing, China. Vaccine 2014;32:5285-9. https://doi.org/10.1016/j.vaccine.2014.07.083
- Song JY, Ha SH, Kee SY, Jeong HW, Cheong HJ, Kim WJ. Debate on annual influenza vaccination in healthcare workers for the same subtype under the vaccine shortage. J Clin Virol 2007;38:149-52. https://doi.org/10.1016/j.jcv.2006.08.022
- Ahout I, Ferwerda G, de Groot R. Influenza vaccination in kids, are you kidding me? J Infect 2014;68 Suppl 1:S100-7. https://doi.org/10.1016/j.jinf.2013.09.019
- Heinonen S, Silvennoinen H, Lehtinen P, Vainionpaa R, Ziegler T, Heikkinen T. Effectiveness of inactivated influenza vaccine in children aged 9 months to 3 years: an observational cohort study. Lancet Infect Dis 2011;11:23-9. https://doi.org/10.1016/S1473-3099(10)70255-3
- Blyth CC, Jacoby P, Effler PV, Kelly H, Smith DW, Robins C, et al. Effectiveness of trivalent flu vaccine in healthy young children. Pediatrics 2014;133:e1218-25. https://doi.org/10.1542/peds.2013-3707
- Kee SY, Lee JS, Cheong HJ, Chun BC, Song JY, Choi WS, et al. Influenza vaccine coverage rates and perceptions on vaccination in South Korea. J Infect 2007;55:273-81. https://doi.org/10.1016/j.jinf.2007.04.354
- Jefferson T, Rivetti A, Harnden A, Di Pietrantonj C, Demicheli V. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev 2008;(2):CD004879.
- Neuzil KM, Edwards KM. Influenza vaccines in children. Semin Pediatr Infect Dis 2002;13:174-81. https://doi.org/10.1053/spid.2002.125860
- McMahon AW, Iskander J, Haber P, Chang S, Woo EJ, Braun MM, et al. Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990-2003. Pediatrics 2005;115:453-60. https://doi.org/10.1542/peds.2004-1519
- Kanra G, Marchisio P, Feiterna-Sperling C, Gaedicke G, Lazar H, Durrer P, et al. Comparison of immunogenicity and tolerability of a virosome-adjuvanted and a split influenza vaccine in children. Pediatr Infect Dis J 2004;23:300-6. https://doi.org/10.1097/00006454-200404000-00005
- Jo YM, Ki SY, Song JY, Choi WS, Kim JY, Seo YB, et al. Immunogenicity and safety of half dose intradermal injection compared to full dose intramuscular injection of influenza vaccine in healthy adults. Infect Chemother 2006;38:259-65.
- Greenberg ME, Lai MH, Hartel GF, Wichems CH, Gittleson C, Bennet J, et al. Response to a monovalent 2009 influenza A (H1N1) vaccine. N Engl J Med 2009;361:2405-13. https://doi.org/10.1056/NEJMoa0907413
- al-Mazrou A, Scheifele DW, Soong T, Bjornson G. Comparison of adverse reactions to whole-virion and splitvirion influenza vaccines in hospital personnel. CMAJ 1991;145:213-8.
- Kim YK, Eun BW, Kim NH, Kang EK, Lee BS, Kim DH, et al. Comparison of immunogenicity and reactogenicity of split versus subunit influenza vaccine in Korean children aged 6-35 months. Scand J Infect Dis 2013;45:460-8. https://doi.org/10.3109/00365548.2012.755267
- Masurel N, Ophof P, de Jong P. Antibody response to immunization with influenza A/USSR/77 (H1N1) virus in young individuals primed or unprimed for A/New Jersey/76 (H1N1) virus. J Hyg (Lond) 1981;87:201-9. https://doi.org/10.1017/S0022172400069412